River Road Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-124,900
Closed -$54.3M 189
2025
Q1
$54.3M Buy
124,900
+9,343
+8% +$3.75M 0.74% 58
2024
Q4
$42.6M Buy
115,557
+10,216
+10% +$4.27M 0.57% 65
2024
Q3
$54.8M Buy
105,341
+9,400
+10% +$5.02M 0.72% 53
2024
Q2
$52M Sell
95,941
-2,821
-3% -$1.49M 0.75% 46
2024
Q1
$51.2M Buy
+98,762
New +$49.1M 0.69% 48
2020
Q4
Sell
-2,150
Closed -$577K 149
2020
Q3
$577K Buy
2,150
+660
+44% +$178K 0.01% 135
2020
Q2
$392K Buy
+1,490
New +$398K 0.01% 137

Other funds holding ELV

River Road Asset Management's ELV Position: Q2 2025 in Review

River Road Asset Management sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 124,900 shares — an estimated $54.3M sold.

River Road Asset Management first reported a position in ELV in Q2 2020 and held it in 7 quarters. The position peaked at $54.8M in Q3 2024. 1,593 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • River Road Asset Management reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • River Road Asset Management sold 124,900 Elevance Health shares in Q2 2025, an estimated $54.3M.
  • River Road Asset Management first reported a position in Elevance Health in Q2 2020 and held it in 7 quarters.
  • River Road Asset Management's Elevance Health position peaked at $54.8M in Q3 2024.
  • 1,593 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on River Road Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.